A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
Clinical trial NCT05918133 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05918133
- Sponsor
- Biotheus Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2026-10-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.